BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
11.03.26
/
50%
€52.12
Target price
11.03.27
€73.15
Performance (%)
-7.67%
Price
02.04.26
€48.12
Summary
This prediction is currently active. With a performance of -7.67%, the BUY prediction for BioMarin Pharmaceutical Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 11.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | -0.681% |
| iShares Core DAX® | 2,49 % |
| iShares Nasdaq 100 | 1,65 % |
| iShares Nikkei 225® | 0,55 % |
| iShares S&P 500 | 1,35 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25